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Background: Recently, Mycobacterial Interspersed Repetitive Unit (MIRU) was
supposed to be associated with drug resistance in Mycobacterium tuberculosis (M.
tuberculosis), but whether the association exists actually in local strains in China was still
unknown. This research was conducted to explore that association and the predictability
of MIRU to drug resistance of Tuberculosis (TB).
Methods: The clinical isolates were collected and the susceptibility test were conducted
with Lowenstein–Jensen (LJ) medium for five anti-TB drug. Based on PCR of MIRU-
VNTR (Variable Number of Tandem Repeat) genotyping, we tested the number of the
repeat unite of MIRU. Then, we used logistic regression to evaluate the association
between 15 MIRU and drug resistance. In addition, we explored the most suitable MIRU
locus of identified MIRU loci for drug resistance by multivariate logistic regression.
Results: Of the 102 strains, one isolate was resistant to rifampicin and one isolate was
resistant to streptomycin. Among these fifteen MIRU, there was a association between
MIRU loci polymorphism and anti-tuberculosis drug resistance, ETRB (P = 0.03,
OR = 0.19, 95% CI 0.05–0.81) and ETRC (P = 0.01, OR = 0.14, 95% CI 0.03–
0.64) were negatively related to isoniazid resistance; MIRU20 (P = 0.05, OR = 2.87,
95% CI 1.01–8.12) was positively associated with ethambutol resistance; and QUB11a
(P = 0.02, OR = 0.79, 95% CI 0.65–0.96) was a negative association factor of
p-aminosalicylic acid resistance.
Conclusion: Our research showed that MIRU loci may predict drug resistance of
tuberculosis in China. However, the mechanism still needs further exploration.
Keywords: Mycobacterium tuberculosis, Mycobacterial Interspersed Repetitive Unit, drug resistance, repeat
units, genotyping
INTRODUCTION
Tuberculosis (TB) caused by Mycobacterium tuberculosis (M. tuberculosis) infection has affected
human beings for 1000s of years. Due to patients defaulting on TB therapy, there has been
an increasing number of drug resistant TB strains, especially multidrug-resistant TB (MDR-TB;
Biadglegne et al., 2014). In 2012, 1.3 million people died from TB, of which 3.6% of all new and
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20% of all recurring cases involved infection with MDR-TB1.
Particularly, the prevalent genotype in East Asia, Beijing genotype
M. tuberculosis, has shown drug resistance (Liu et al., 2012). Drug
resistance, especially MDR-TB, has made treating TB extremely
difficult.
Genetic factors play important roles in drug resistance specific
to TB treatment. For example, isoniazid (INH), rifampicin
(RFP), and streptomycin (SM) resistance were found to be
related to genes katG315 (Lu et al., 2014), rpoB513 (Jun et al.,
2009), and gidB A80P (Perdigão et al., 2014), respectively. In
addition, an eﬄux pump capable of eﬄuxion of INH was
found to be related to five genes (Rodrigues et al., 2012). The
underlying mechanisms of these resistances, however, are still
unclear.
Mycobacterial Interspersed Repetitive Unit is a type of the
“minisatellite” VNTR (Variable Number of Tandem Repeat)
with the length of MIRU repetitive unit ranging from 50 to
100 base pairs (bp) (Supply et al., 2001). A series of studies
suggested that MIRU loci could be involved in the expression
regulation of neighboring genes. For example, when the repeat
units of Mtub39 locus repeat fourth, the expression level of
its downstream gene lpdA was 12-fold as that of the same
gene when the frequency of repeat units of Mtub39 locus
was 1 (Akhtar et al., 2009). Similar results were showed in
another experiment (Pérez-Lago et al., 2013): ∼56% increase in
expression level of lpdA when the frequency of repeat units of
Mtub39 was from 3 to 4. Tantivitayakul et al. (2010) also found
that MIRU10 could promote the expression of downstream gene
gfp. In addition, different frequencies of tandem repeats may
influence the folding of DNA, thereby affecting the attraction,
binding, and interaction of transcription factors (Supply et al.,
1997).
Our previous studies have confirmed/verified the hypothesis
that some MIRU loci polymorphism were related to anti-
tuberculosis drug resistance (Yu-feng et al., 2015). This study
was conducted using strains worldwidely, of which 54 were
from Germany, 20 were from Ghana, 20 were from Uganda,
and 15 were from former Soviet Union. However, whether the
association between MIRU loci and drug resistance exists in
China or other countries were still unknown. Therefore, in this
study, we sampled 102 clinical strains of M. tuberculosis from
eastern China to explorethe association between the MIRU loci
and drug resistance.
MATERIALS AND METHODS
Selection of Clinical Isolates
A total of 102 clinical isolates of M. tuberculosis were selected
from sputum of patients who were recruited between 2009 and
2012 in the eastern area of Anhui Province, China. The standard
M. tuberculosis strain H37Rv was used as the control isolate,
which was courteously provided by Dr. Chuanyou Li of Beijing
Chest Hospital, China.
1http://www.who.int/tb/publications/global_report/en/
Drug Susceptibility Testing
Four first-line anti-tuberculosis drugs including RFP, INH, SM,
ethambutol (EMB), and one second-line drug of p-aminosalicylic
acid (PAS) were incorporated into LJ medium, at the following
concentrations: INH, 0.2 µg/mL; RFP, 40.0 µg/mL; SM,
4.0 µg/mL; EMB, 2.0 µg/mL; PAS, 1.0 µg/mL2. The proportion
method was used to detect the drug-resistance of the M.
tuberculosis. Strain was scored as resistant to a specific
drug, or defined as sensitive if its growth rate was <1%
compared to the control. Strain isolation, identification,
and drug susceptibility tests (DST) were performed at the
laboratory of Ma Anshan Centre for Disease Control and
Prevention.
MIRU Loci Selection
According to the Chinese genotyping handbook and protocol
referenced literature (Lee et al., 2014), 15 MIRU loci were selected
in this study. The primer sequence and length of repeat units of
each MIRU locus was shown in Table 1.
2http://www.cdc.gov/tb/topic/laboratory/Drug_testing.htm
TABLE 1 | The promoter sequence and the length of repeat units of 15
MIRU loci.
MIRU locus Promoter sequence(5′–3′) Length of repeat
units (bp)
ETRC F:GTGAGTCGCTGCAGAACCTGCAG
R:GGCGTCTTGACCTCCACGAGTG
45
ETR-D F:CAGGTCACAACGAGAGGAAGAGC
R:GCGGATCGGCCAGCGACTCCTC
45
ETR-E F:CTTCGGCGTCGAAGAGAGCCTC
R:CGGAACGCTGGTCACCACCTAAG
45
QUB11a F:CCCATCCCGCTTAGCACATTCGTA
R:TTCAGGGGGGATCCGGGA
42
QUB11b F:CGTAAGGGGGATGCGGGAAATAGG
R:CGAAGTGAATGGTGGCAT
42
MIRU-10 F:GTTCTTGACCAACTGCAGTCGTCC
R:GCCACCTTGGTGATCAGCTACCT
47
MIRU-16 F:TCGGTGATCGGGTCCAGTCCAAGTA
R:CCCGTCGTGCAGCCCTGGTAC
46
MIRU-20 F:TCGGAGAGATGCCCTTCGAGTTAG
R:GGAGACCGCGACCAGGTACTTGTA
48
MIRU-26 F:CCCGCCTTCGAAACGTCGCT
R:TGGACATAGGCGACCAGGCGAATA
44
MIRU-27 F:TCGAAAGCCTCTGCGTGCCAGTAA
R:GCGATGTGAGCGTGCCACTCAA
46
MTUB-31 F:GTGACGTTTACCGTGCTCTATTTC
R:GTCGTCGGACAGTTCTAGCTTT
46
MIRU-39 F:CGCATCGACAAACTGGAGCCAAAC
R:CGGAAACGTCTACGCCCCACACAT
48
MIRU-40 F:AAGCGCAAGAGCACCAAG
R:GTGGGCTTGTACTTGCGAAT
38
ETRA F:AAATCGGTCCCATCACCTTCTTAT
R:CGAAGCCTGGGGTGCCCGCGATTT
48
ETR-B F:GCGAACACCAGGACAGCATCATG
R:GGCATGCCGGTGATCGAGTGG
44
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DNA Preparation and PCR Amplification
Sputum specimens were treated with 4% NaOH and inoculated
on LJ medium for 4–6 weeks. The colony of 1–2 rings was
dissolved in 400 µL sterile distilled water on the vortex device.
In addition, the liquid supernatant was stored with −20◦C
cryopreservation after being boiled in a water bath for 30 min
and clarified by centrifugation at 4◦C at 12,000 rpm for
15 min.
Each PCR mix contained 12.5 µL of 2x PCR buffer (Tiangen
Biotech Co., Ltd., Beijing, China), 0.25 µM of each primer
and 6 µL of sterile distilled water. Four microliters of template
DNA was added to each reaction mixture. Following an initial
denaturation at 95◦C for 10 min the PCRs were subjected to
40 thermocycles of 94◦C for 60 s, 60◦C for 60 s, and 72◦C
for 90 s. This was followed by a final extension at 72◦C
for 10 min. Positive and negative control reactions, in which
PCR mixes were inoculated with 4 µL of boiled cells from
the M. tuberculosis H37RV strain and sterile distilled water,
respectively, were performed with each set of reactions (Lee et al.,
2014).
The PCR products were electrophoretically separated on
2% agarose gel (Life Technologies, Grand Island, NY, USA)
in 1x Tris-boric acid-EDTA buffer (Tiangen). A 100-bp DNA
stepladder (Thermo Fisher Scientific Inc., Waltham, MA, USA)
was used as the marker.
Data Analysis
The allelic diversity (h-value) of MIRU loci, individually and in
combination, was calculated by the following equation: h = 1−∑
x2i [n/(n− 1)], where n is the number of isolates and xi is the
frequency of its allele at the locus (Kremer et al., 2005).
Univariate logistic regression with the enter method was used
to initially evaluate the associations between MIRU loci and
anti-tuberculosis drug resistance. Multivariate logistic regression
with the stepwise method was used to analyze the major risk
and protective factors of MIRU loci initially selected from the
univariate logistic regression.
RESULTS
Distribution of Repeat Units,
Polymorphism, and Drug Resistance
Rate of MIRU Loci
The number of repeat units in the 15 MIRU loci ranged from 0
to 12. The h-value, which measures the allelic diversity of MIRU
TABLE 2 | Association between the MIRU loci and drug resistance in univariate logistic regression.
Model Loci β SE P OR 95% CI for OR
Lower limit Upper limit
INH MIRU40 –0.88 0.43 0.04 0.41 0.18 0.97
ETRB –1.97 0.68 <0.005 0.14 0.04 0.53
ETRC –2.26 0.80 <0.005 0.10 0.02 0.50
EMB MIRU20 1.05 0.53 0.048 2.87 1.01 8.12
MIRU27 –1.27 0.60 0.03 0.28 0.09 0.91
MIRU40 –1.26 0.63 0.047 0.29 0.08 0.98
ETRC –1.45 0.63 0.02 0.23 0.07 0.80
PAS ETRA –0.96 0.42 0.02 0.38 0.17 0.87
ETRB –1.31 0.63 0.04 0.27 0.08 0.92
QUB11a –0.24 0.10 0.02 0.79 0.65 0.96
TABLE 3 | Association between the MIRU loci and drug resistance in multivariate logistic regression.
Model Loci β SE P OR 95% CI for OR
Lower limit Upper limit
INH ETRB –1.66 0.74 0.03 0.19 0.05 0.81
ETRC –1.98 0.79 0.01 0.14 0.03 0.64
Constant 7.53 2.62 0.00
EMB MIRU20 1.05 0.53 0.05 2.87 1.01 8.12
Constant –5.83 1.58 0.00
PZA QUB11a –0.24 0.10 0.02 0.79 0.65 0.96
Constant 0.38 0.63 0.54
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loci, ranged from 0.03 for ETRC to 0.77 for OUB11a. Of the
drug resistance, 22 were resistant to INH, 20 were resistant to
RFP, 5 were resistant to EMB, and 26 were resistant to PAS. The
anti-TB drug rates of tuberculosis strains with different copies
of MIRU locus unit ranged from 0.0 to 100.0% (Supplementary
Table 1).
Association between MIRU Loci and
Drug-Resistance in M. tuberculosis
According to univariate logistic regression analysis, we found
a number of MIRU loci associated with the drug resistance
(Table 2). For example, ETRB was associated with INH resistance
(P < 0.005). The strain with one repeat of ETRB is the most drug
resistant: 6 out of 10 are INH resistant, versus 16 out of 87 being
resistant for strains with two repeats of ETRB (Supplementary
Table 1). The corresponding odds ratio (OR) was estimated to
be 0.14. Overall, 3, 4, and 3 out of the 15 MIRU loci showed
resistance to INH, EMB, PAZ, respectively. No MIRU loci were
associated with RFP and SM resistance.
In addition, the ability of the MIRU loci in predicting drug
resistance was studied by multivariate logistic regression analysis.
Overall, three models were found to provide predictions. For
example, with MIRU40, ETRB, and ETRC were the most suitable
MIRU loci for the predictive model. We also found other models
being able to improve prediction for EMB and PAS resistance
(Table 3). The models detected here could potentially aid in
future drug resistance prediction.
DISCUSSION
In the present study, we found that ETRB and ETRC were the
major predicted factors for INH resistance and QUB11a was the
leading predicted factor for PAS resistance. The allelic diversity
of QUB11a (0.77) was high but that of ETRB (0.25) and ETRC
(0.17) was low.
Although no functions have been found for many MIRU loci,
there are evidences that certain MIRU loci can affect nearby gene
activities. For example, Yao et al. found that Mtub-39 could affect
the promotor activity of the downstream genes, and subsequently
regulate the expression of the genes3. Along with our previous
results (Wen et al., 2015), the identified resistance-related MIRU
in our study provide good hints for generating function-related
hypotheses for these MIRU loci, which was briefly described
in the following paragraphs. Particularly, MIRU loci might
exert functions by regulating the expression of neighboring
genes.
For INH resistance, ETRB was immediately downstream
of gene qcrB. It has been reported that overexpression of
qcrB in Mycobacterium bovis bacillus Calmette–Guérin (BCG)
enabled the bacteria to survive at imidazo[1,2-a]pyridines(IP)
concentrations that would normally be lethal (Abrahams et al.,
2012). Cytochrome b encoded by qcrB was the subunit of bc1
compound which formed a key component in the electron
3http://www.stmopen.net/research-on-relationship-between-polymorphisms-of-
mtub-39-and-expression-of-downstream-genes-of-mycobacterium-tuberculosis/
transport chain and included in superoxide generation (Crofts
et al., 2008). Previous studies have found that repeated ALU
sequences can depress the expression of the reporter gene GFP
(Li et al., 2012). We hypothesized that increased copy numbers
of ETRB units might inhibit the expression of qcrB, and lead to
sensitivity to INH, whose anti-tuberculosis function is associated
with the electron transport chain (Herman and Weber, 1980; Lee
et al., 2013). ETRC, another protective factor for INH resistance,
is located 210 bp upstream of Rv0488.
For EMB resistance, MIRU20 locus is a protective factor. The
frequency of MIRU20, located 19 bp upstream of Rv1817, is 2 in
H37Rv strain. The function of Rv1817 is still unknown, and is
believed to be probably involved in cellular metabolism and metal
utilization (Camacho et al., 1999). Interestingly, Zhang et al.
(2013) reported that the mutation of Rv1817 may be associated
with ofloxacin and kanamycin resistance but not EMB. Thus,
we hypothesized that MIRU20 may stimulate the expression of
Rv1817, and result in the EMB resistance. However, potential
molecular mechanisms about Rv1817 involved in EMB resistance
have not been found previously.
QUB11a, a major protective factor for PAS resistance, is
included in the gene PPE34. Expression of a recombinant PPE34
protein in Mycobacterium smegmatis showed that PPE34 was
likely to be both exposed on the surface of the cell and associated
with the cell wall (Lu et al., 2009). PPE34 is polymorphic and
related to changes in the numbers of tandem repeat. The high
number of copy units of QUB11a may influence the activity of
the expression protein of gene PPE34 and then impair the barrier
function of cell wall to have M. tuberculosis be resistant to PAS.
In this study, we found that MIRU 40 was related to the
increased INH resistance, which was the same as that in our
previous results (Wen et al., 2015).
CONCLUSION
Our research showed that MIRU loci may predict drug resistance
of tuberculosis in China. However, the mechanism and exact
predictive model still need further exploration.
At last, a number of limitations exist in our study. First,
only 15 MIRU loci of M. tuberculosis were selected. This is
partially because our work was designed based on the tuberculosis
genotyping guideline of Chinese version as the strains were
all from China and we thought the initial research method
would be better according to the handbook of China version.
Second, there is still lack of direct evidence for the mechanisms
mentioned above. Further functional study is needed to clarify
whether the abnormal expression of neighboring genes can cause
resistance. Third, the study may need to include other MIRU loci
to investigate the association of MIRU loci with drug resistance
in M. tuberculosis.
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